Portable MRI maker Hyperfine's Q3 prelim revenue beats estimates; FY outlook reaffirmed
Portable MRI maker Hyperfine's Q3 prelim revenue beats estimates; FY outlook reaffirmed
Overview
US portable MRI maker's preliminary Q3 revenue grew 53% sequentially, beating analyst expectations
Company reaffirmed full-year 2026 revenue outlook of $20-22 mln
Q3 revenue exceeded net cash burn for first time, showing improved operating leverage
Outlook
Hyperfine reaffirms 2026 revenue outlook of $20 mln to $22 mln
Company maintains 2026 net cash burn guidance at $26 mln to $28 mln
Company sees continued adoption across hospital, office-based, wellness, and international markets
Result Drivers
COMMERCIAL EXPANSION - Co cited strong momentum across health systems, new care sites, and international rollout of Model 2 Swoop system
OPERATING DISCIPLINE - Co said lower cash burn reflected improved operating discipline in Q3
NEW CARE SETTINGS - Co highlighted adoption of its portable MRI in office-based, wellness, and mobile settings
Company press release: ID:nBw9Y1PZ0a
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Prelim Sales | Beat | $6 mln | $5.12 mln (3 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Hyperfine, Inc. is $2.00, about 135.6% above its October 7 closing price of $0.85
Reuters Recommended Reads
Oct 6 - Innovative Eyewear preliminary Q3 net sales rise to record high
Oct 8 - AngioDynamics Q1 sales beat on med tech segment growth
Oct 5 - Vaxcyte shares surge as pneumococcal vaccine succeeds in late-stage trial
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Hyperfine
See all newsPortable MRI maker Hyperfine's Q3 prelim revenue beats estimates; FY outlook reaffirmed
Brief: Hyperfine, Inc. Q3 Sales USD 6 Million
Hyperfine Inc reports results for the quarter ended June 30 - Earnings Summary
Portable MRI maker Hyperfine's Q2 revenue rises less than expected
Brief: Hyperfine, Inc. Q2 EPS USD -0.09